N.E.W. Advisory Services’s Cytosorbents Corp CTSO Stock Holding History

N.E.W. Advisory Services’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,720	Closed	-$3.48K	–	849
2025 Q2	$3.48K	Hold	2,720	–	–	﹤0.01%	691
2025 Q1	$2.72K	Buy	+2,720	New	+$2.87K	﹤0.01%	764

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

N.E.W. Advisory Services's CTSO Position: Q3 2025 in Review

N.E.W. Advisory Services sold out of Cytosorbents Corp (CTSO) in Q3 2025, closing a stake of 2,720 shares — an estimated $3.48K sold.

N.E.W. Advisory Services first reported a position in CTSO in Q1 2025 and held it in 2 quarters. The position peaked at $3.48K in Q2 2025. 49 funds tracked by Wall St. Rank hold CTSO as of Q3 2025.

N.E.W. Advisory Services reported no remaining Cytosorbents Corp position as of Q3 2025 after selling out during the quarter.
N.E.W. Advisory Services sold 2,720 Cytosorbents Corp shares in Q3 2025, an estimated $3.48K.
N.E.W. Advisory Services first reported a position in Cytosorbents Corp in Q1 2025 and held it in 2 quarters.
N.E.W. Advisory Services's Cytosorbents Corp position peaked at $3.48K in Q2 2025.
49 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2025.

Based on N.E.W. Advisory Services's 13F filing for Q3 2025, filed 27 Oct 2025.